Literature DB >> 23259424

Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers.

Loredana Pellegrino1, Jimmy Jacob, Laura Roca-Alonso, Jonathan Krell, Leandro Castellano, Adam E Frampton.   

Abstract

Several studies have implicated miRNAs in the initiation and progression of human cancers. Examining the biogenesis pathways that generate these important regulatory molecules has revealed new mechanisms for tumor development. Altered expression of the endoribonuclease Dicer in many tumors has given new hope to unraveling the complex relationship between miRNA processing and cancer. This may provide further insight into mechanisms for targeting multiple genes that are critical for the malignant phenotype of several cancers. The evaluated article demonstrates that Dicer is transcriptionally regulated by Sox4 and reduced levels of this transcription factor consequently leads to a reduction in expression, and therefore deregulation of cancer-related miRNAs in melanoma. Reduced Dicer expression in malignant melanoma is an independent predictor of poor survival. In this review, we assess the prognostic significance of Dicer expression in different tumor types.

Entities:  

Year:  2013        PMID: 23259424     DOI: 10.1586/era.12.150

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  9 in total

1.  Mutation Scanning of D1705 and D1709 in the RNAse IIIb Domain of MicroRNA Processing Enzyme Dicer in Cutaneous Melanoma.

Authors:  Michael Sand; Falk G Bechara; Marina Skrygan; Daniel Sand; Thilo Gambichler; Michael Bromba; Eggert Stockfleth; Schapoor Hessam
Journal:  Pathol Oncol Res       Date:  2015-12-18       Impact factor: 3.201

2.  The epigenetic regulation of Dicer and microRNA biogenesis by Panobinostat.

Authors:  Nicholas C Hoffend; William J Magner; Thomas B Tomasi
Journal:  Epigenetics       Date:  2016-12-09       Impact factor: 4.528

3.  Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF.

Authors:  Danhua Zhang; Jianping Zhou; Ming Dong
Journal:  Dig Dis Sci       Date:  2013-12-27       Impact factor: 3.199

Review 4.  MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.

Authors:  Sara Correia Marques; Maria Bach Laursen; Julie Støve Bødker; Malene Krag Kjeldsen; Steffen Falgreen; Alexander Schmitz; Martin Bøgsted; Hans Erik Johnsen; Karen Dybkaer
Journal:  Oncotarget       Date:  2015-01-01

5.  The modulation of Dicer regulates tumor immunogenicity in melanoma.

Authors:  Nicholas C Hoffend; William J Magner; Thomas B Tomasi
Journal:  Oncotarget       Date:  2016-07-26

6.  Strong reduction of AGO2 expression in melanoma and cellular consequences.

Authors:  D Völler; J Reinders; G Meister; A-K Bosserhoff
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

Review 7.  microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer.

Authors:  Silvia Anna Ciafrè; Silvia Galardi
Journal:  RNA Biol       Date:  2013-04-12       Impact factor: 4.652

8.  An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas.

Authors:  Bora Kim; Jae-Ho Lee; Jong Wook Park; Taeg Kyu Kwon; Seong Kyu Baek; Ilseon Hwang; Shin Kim
Journal:  Clin Exp Med       Date:  2013-06-18       Impact factor: 3.984

9.  Argonaute Family Protein Expression in Normal Tissue and Cancer Entities.

Authors:  Daniel Völler; Lisa Linck; Astrid Bruckmann; Judith Hauptmann; Rainer Deutzmann; Gunter Meister; Anja Katrin Bosserhoff
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.